NOZZOLI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 683
EU - Europa 427
AS - Asia 113
OC - Oceania 7
Totale 1.230
Nazione #
US - Stati Uniti d'America 680
RU - Federazione Russa 202
IT - Italia 110
SG - Singapore 45
IE - Irlanda 31
HK - Hong Kong 29
SE - Svezia 28
CN - Cina 22
CH - Svizzera 19
FI - Finlandia 12
DE - Germania 9
AU - Australia 7
ID - Indonesia 5
TR - Turchia 5
ES - Italia 4
CA - Canada 3
FR - Francia 3
GB - Regno Unito 3
JO - Giordania 3
KR - Corea 3
AT - Austria 2
NL - Olanda 2
EE - Estonia 1
IN - India 1
UA - Ucraina 1
Totale 1.230
Città #
Santa Clara 229
Fairfield 62
Ashburn 49
Chandler 42
Woodbridge 42
Singapore 38
Dublin 31
Cambridge 27
Seattle 26
Wilmington 26
Florence 22
Hong Kong 22
Milan 21
Bern 19
Houston 16
Altamura 12
Lawrence 12
Ann Arbor 11
Princeton 10
Kent 8
Boston 7
Melbourne 7
Moscow 7
Boardman 6
Shanghai 6
Helsinki 5
Izmir 5
Jakarta 5
San Diego 5
Barcelona 4
Medford 4
Prato 4
Rome 4
Yubileyny 4
Andover 3
Beijing 3
Buffalo 3
Falls Church 3
Livorno 3
Los Angeles 3
Paris 3
Seoul 3
Siena 3
Beilngries 2
Brescia 2
Frankfurt am Main 2
Jacksonville 2
Lappeenranta 2
New York 2
Palermo 2
Romola 2
Salerno 2
Taranto 2
Vienna 2
West Jordan 2
Amsterdam 1
Arezzo 1
Bologna 1
Carrara 1
Castelnuovo Rangone 1
Harbin 1
Hengyang 1
Hillsboro 1
London 1
Magdeburg 1
Montreal 1
Nembro 1
Norwalk 1
Ottawa 1
Pisa 1
Pune 1
Redwood City 1
Tallinn 1
Toronto 1
Vasto 1
Wuhan 1
Xiamen 1
Yancheng 1
Totale 872
Nome #
New patterns of relapse in multiple myeloma: A case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation 133
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo 128
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 124
Impact of disease status on outcome in relapsed and refractory multiple myeloma treated with lenalidomide 124
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 122
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 109
Allogeneic Stem Cell Transplantation In Multiple Myeloma Relapsed After Autograft: A Multicenter Retrospective Study Based on Donor Availability. 106
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 94
The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information. 74
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 70
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 69
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 68
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series 26
Totale 1.247
Categoria #
all - tutte 3.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 0 0 17 17 18 8 9 2
2020/202179 9 9 12 6 2 6 8 4 8 5 5 5
2021/202265 1 1 7 7 1 10 0 8 1 5 7 17
2022/2023182 15 33 11 10 13 29 16 13 19 3 1 19
2023/2024132 1 21 14 6 7 13 10 20 3 6 15 16
2024/2025579 29 71 41 122 193 116 7 0 0 0 0 0
Totale 1.247